FDA Targets Generics Manufacturer Mylan for Continuous Quality Problems, an Industrial Info Market Brief

Generics manufacturer Mylan once enjoyed an ongoing clean safety record with the U.S. Food and Drug Administration (FDA). Today, the company is finding itself repeatedly in the agency's spotlight due to problems with quality. With a vast global network of manufacturing plants, the company produces active pharmaceutical ingredients (APIs) for a wide range of generic drug products, along with final formulations.